STOCK TITAN

Precigen (PGEN) CFO gains 87,500 shares from RSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Precigen, Inc. Chief Financial Officer Harry Thomasian Jr. exercised restricted stock units into common stock as part of his compensation. On May 23, 2026, he acquired 87,500 shares of common stock through the conversion of restricted stock units, with no open-market purchase or sale reported.

Following the transaction, he directly holds 596,419 shares of common stock and 87,500 restricted stock units. The footnotes explain that these RSUs were granted on June 26, 2025, with 50% vesting on May 23, 2026 and the remaining units vesting in equal quarterly installments over the next three years.

Positive

  • None.

Negative

  • None.

Insights

Routine RSU vesting increases CFO’s shareholdings without market trades.

The filing shows 87,500 restricted stock units converting into common stock for Precigen’s CFO on May 23, 2026. This is coded as an option/derivative exercise rather than an open-market buy or sell, indicating routine equity compensation vesting.

After the conversion, he holds 596,419 common shares and 87,500 RSUs. Footnotes state these RSUs were granted on June 26, 2025, with half vesting on May 23, 2026 and the rest vesting quarterly over three years, suggesting an ongoing, scheduled compensation structure rather than discretionary trading.

Insider Thomasian Harry Jr.
Role Chief Financial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 87,500 $0.00 --
Exercise Common Stock 87,500 $0.00 --
Holdings After Transaction: Restricted Stock Units — 87,500 shares (Direct, null); Common Stock — 596,419 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.
RSUs converted 87,500 shares Restricted stock units converted to common stock on May 23, 2026
Common shares after transaction 596,419 shares CFO direct common stock holdings following conversion
Remaining RSUs 87,500 units Restricted stock units held after transaction, vesting over three years
Transaction price per share $0.0000 RSU conversion price per share reported in Form 4
Vest date of 50% RSUs May 23, 2026 Date when half of June 26, 2025 RSU grant vested
RSU grant date June 26, 2025 Grant date for the RSUs referenced in footnotes
Restricted Stock Units financial
"The filing identifies the derivative security as "Restricted Stock Units" tied to common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
vested financial
"Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026."
exercise or conversion of derivative security financial
"The transaction code description is "Exercise or conversion of derivative security" for the RSUs."
Chief Financial Officer financial
"The reporting person is identified as the company’s Chief Financial Officer."
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thomasian Harry Jr.

(Last)(First)(Middle)
20374 SENECA MEADOWS PARKWAY

(Street)
GERMANTOWN MARYLAND 20876

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/23/2026M87,500A(1)596,419D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/23/2026M87,500 (2) (2)Common Stock87,500$087,500D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
2. Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact05/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Precigen (PGEN) report for its CFO?

Precigen reported its CFO, Harry Thomasian Jr., converted 87,500 restricted stock units into common stock on May 23, 2026. This increased his direct holdings without any open-market purchase or sale, reflecting routine equity compensation vesting rather than a discretionary trade.

How many Precigen (PGEN) shares does the CFO hold after this Form 4?

After the reported transaction, the CFO directly holds 596,419 shares of Precigen common stock. In addition, he holds 87,500 restricted stock units, which represent rights to receive more shares as they vest over a future three-year schedule.

What is the size of the RSU conversion reported for Precigen (PGEN)?

The Form 4 shows 87,500 restricted stock units converting into 87,500 shares of Precigen common stock. Each RSU represents a contingent right to receive one share, so the vesting directly increased the CFO’s share count by the same number of units.

Were any Precigen (PGEN) shares sold in this insider transaction?

No, the filing does not report any share sales. It shows an exercise or conversion of 87,500 restricted stock units into common stock, increasing the CFO’s holdings, with no open-market sale or tax-withholding disposition reported in this Form 4.

How will the remaining Precigen (PGEN) RSUs for the CFO vest?

Footnotes state that 50% of the RSUs granted on June 26, 2025 vested on May 23, 2026. The remaining restricted stock units will vest in equal quarterly installments over three years, providing a staggered equity compensation schedule tied to ongoing service.

What does each Precigen (PGEN) restricted stock unit represent for the CFO?

Each restricted stock unit represents a contingent right to receive one share of Precigen common stock. As the RSUs vest over time, they convert into common shares, increasing the holder’s equity stake without requiring cash payment at exercise.